Skip to content
Trial Eligibility
Menu

SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight

NCT07850050

This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study is open to women up to 65 years of age who are living with overweight or obesity and are going through or have finished menopause. People can join this study if they have a Body Mass Index (BMI) of 30 kg/m² or more, or if their BMI is 27 kg/m² or more and they have one or more weight related health problems. Participants must also have tried to lose weight by dieting at least once in the past without success. People with pre-existing diabetes cannot take part in this study.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Obesity

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
45 to 65 years
Sex
Female
Healthy volunteers
Not accepted
Sponsor
Boehringer Ingelheim
Last updated on ClinicalTrials.gov
November 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 3

  • The Center for Diabetes and Endocrine Care · Fort Lauderdale, FL
  • Flourish Research · Merritt Island, FL
  • West Orange Endocrinology, PA · Ocoee, FL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.